These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26579364)

  • 1. Three-dimensional DEM-CFD analysis of air-flow-induced detachment of API particles from carrier particles in dry powder inhalers.
    Yang J; Wu CY; Adams M
    Acta Pharm Sin B; 2014 Feb; 4(1):52-9. PubMed ID: 26579364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential and constraints for the application of CFD combined with Lagrangian particle tracking to dry powder inhalers.
    Sommerfeld M; Cui Y; Schmalfuß S
    Eur J Pharm Sci; 2019 Feb; 128():299-324. PubMed ID: 30553814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DEM analysis of the effect of particle-wall impact on the dispersion performance in carrier-based dry powder inhalers.
    Yang J; Wu CY; Adams M
    Int J Pharm; 2015 Jun; 487(1-2):32-8. PubMed ID: 25845718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle-based coarse-grained approach for simulating dry powder inhaler.
    Liu X; Sulaiman M; Kolehmainen J; Ozel A; Sundaresan S
    Int J Pharm; 2021 Sep; 606():120821. PubMed ID: 34171427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFD-DEM investigation of the effects of aperture size for a capsule-based dry powder inhaler.
    Zhu Q; Kakhi M; Jayasundara C; Walenga R; Behara SRB; Chan HK; Yang R
    Int J Pharm; 2023 Nov; 647():123556. PubMed ID: 37890648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A real-time and modular approach for quick detection and mechanism exploration of DPIs with different carrier particle sizes.
    Cui Y; Huang Y; Zhang X; Lu X; Xue J; Wang G; Hu P; Yue X; Zhao Z; Pan X; Wu C
    Acta Pharm Sin B; 2022 Jan; 12(1):437-450. PubMed ID: 35127397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating inter-patient variability of dispersion in dry powder inhalers using CFD-DEM simulations.
    Benque B; Khinast JG
    Eur J Pharm Sci; 2021 Jan; 156():105574. PubMed ID: 32980431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the motion of hard-shell capsules in dry powder inhalers.
    Benque B; Khinast JG
    Int J Pharm; 2019 Aug; 567():118481. PubMed ID: 31260784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capsule-Based dry powder inhaler evaluation using CFD-DEM simulations and next generation impactor data.
    Almeida LC; Bharadwaj R; Eliahu A; Wassgren CR; Nagapudi K; Muliadi AR
    Eur J Pharm Sci; 2022 Aug; 175():106226. PubMed ID: 35643378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete Modelling of Powder Dispersion in Dry Powder Inhalers - A Brief Review.
    Tong Z; Yu A; Chan HK; Yang R
    Curr Pharm Des; 2015; 21(27):3966-73. PubMed ID: 26290194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the optimisation and adaptation of dry powder inhalers.
    Cui Y; Schmalfuß S; Zellnitz S; Sommerfeld M; Urbanetz N
    Int J Pharm; 2014 Aug; 470(1-2):120-32. PubMed ID: 24792975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards quantitative prediction of the performance of dry powder inhalers by multi-scale simulations and experiments.
    Nguyen D; Remmelgas J; Björn IN; van Wachem B; Thalberg K
    Int J Pharm; 2018 Aug; 547(1-2):31-43. PubMed ID: 29792988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier particle emission and dispersion in transient CFD-DEM simulations of a capsule-based DPI.
    Benque B; Khinast JG
    Eur J Pharm Sci; 2022 Jan; 168():106073. PubMed ID: 34774996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Numerical Modelling of Agglomeration and Deagglomeration in Dry Powder Inhalers: A Review.
    Yang J; Wu CY; Adams M
    Curr Pharm Des; 2015; 21(40):5915-22. PubMed ID: 26446462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approach for real-time monitoring of carrier-based DPIs delivery process
    Zhang X; Cui Y; Liang R; Wang G; Yue X; Zhao Z; Huang Z; Huang Y; Geng J; Pan X; Wu C
    Acta Pharm Sin B; 2020 Jul; 10(7):1331-1346. PubMed ID: 32874832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CFD-DEM investigation of powder transport and aerosolization in ELLIPTA® dry powder inhaler.
    Sulaiman M; Liu X; Sundaresan S
    Powder Technol; 2022 Sep; 409():. PubMed ID: 36348745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Numerical Study on Particle Adhesion in Dry Powder Inhaler Device.
    Mitani R; Ohsaki S; Nakamura H; Watano S
    Chem Pharm Bull (Tokyo); 2020; 68(8):726-736. PubMed ID: 32741913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numerical Modeling of Particle Dynamics Inside a Dry Powder Inhaler.
    Šušteršič T; Bodić A; Ignjatović J; Cvijić S; Ibrić S; Filipović N
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dry powder inhaler device influence on carrier particle performance.
    Donovan MJ; Kim SH; Raman V; Smyth HD
    J Pharm Sci; 2012 Mar; 101(3):1097-107. PubMed ID: 22095397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition and fine particle production during dynamic flow in a dry powder inhaler: a CFD approach.
    Milenkovic J; Alexopoulos AH; Kiparissides C
    Int J Pharm; 2014 Jan; 461(1-2):129-36. PubMed ID: 24296048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.